GE HealthCare Technologies (NASDAQ:GEHC) Stock Gets Price Target Boost from JPMorgan Chase & Co.

GE HealthCare Technologies (NASDAQ:GEHC) had its price target lifted by stock analysts at JPMorgan Chase & Co. from $70.00 to $80.00 in a report issued on Thursday, Benzinga reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 4.68% from the company’s previous close.

A number of other equities research analysts have also issued reports on GEHC. Barclays lifted their target price on shares of GE HealthCare Technologies from $85.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday. Needham & Company LLC reaffirmed a “buy” rating and issued a $93.00 price target on shares of GE HealthCare Technologies in a research note on Monday, October 5th. Bank of America reiterated a “neutral” rating on shares of GE HealthCare Technologies in a report on Thursday. UBS Group lifted their price objective on GE HealthCare Technologies from $67.00 to $73.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. Finally, Citigroup boosted their target price on GE HealthCare Technologies from $71.00 to $79.00 and gave the company a “neutral” rating in a research note on Thursday. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $80.57.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC traded up $0.60 on Thursday, reaching $76.42. 4,639,326 shares of the company traded hands, compared to its average volume of 4,242,644. GE HealthCare Technologies has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The company’s 50 day moving average is $68.37 and its 200-day moving average is $70.17. The stock has a market capitalization of $34.52 billion, a PE ratio of 17.53, a P/E/G ratio of 1.89 and a beta of 0.73. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.26 and a quick ratio of 0.97.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 28th. The company reported $1.34 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.14. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The firm had revenue of $5.51 billion for the quarter, compared to analysts’ expectations of $5.35 billion. During the same period in the previous year, the company posted $1.07 EPS. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. As a group, analysts anticipate that GE HealthCare Technologies will post 4.93 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. State Street Corp boosted its stake in GE HealthCare Technologies by 1.6% during the second quarter. State Street Corp now owns 20,861,566 shares of the company’s stock worth $1,335,349,000 after buying an additional 323,090 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC raised its stake in shares of GE HealthCare Technologies by 13.2% in the 2nd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,455,814 shares of the company’s stock valued at $861,307,000 after buying an additional 1,571,226 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of GE HealthCare Technologies by 2.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 5,399,439 shares of the company’s stock valued at $384,219,000 after buying an additional 105,995 shares in the last quarter. Van ECK Associates Corp lifted its holdings in shares of GE HealthCare Technologies by 4.1% during the 2nd quarter. Van ECK Associates Corp now owns 4,482,631 shares of the company’s stock worth $286,933,000 after acquiring an additional 177,028 shares during the period. Finally, Mizuho Markets Cayman LP lifted its holdings in shares of GE HealthCare Technologies by 173.2% during the 1st quarter. Mizuho Markets Cayman LP now owns 3,068,500 shares of the company’s stock worth $218,416,000 after acquiring an additional 1,945,500 shares during the period. Institutional investors own 82.06% of the company’s stock.

More GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Quarterly earnings beat expectations: GEHC reported third-quarter adjusted EPS of $1.34, versus the $1.20–$1.21 analyst consensus, while revenue of $5.51 billion exceeded estimates of approximately $5.35 billion and increased 7.2% year over year. GE HealthCare reports third quarter 2026 financial results
• Positive Sentiment: Guidance was raised: Management increased its 2026 outlook, including organic revenue growth of about 4%, adjusted EPS of $4.95–$5.05 and free cash flow of at least $1.6 billion. Broad-based demand, stronger margins and healthy hospital spending contributed to the upgrade. GE HealthCare lifts forecasts on healthy hospital spending
• Positive Sentiment: Growth initiatives strengthen the outlook: Analysts highlighted 6.2% organic growth, margin expansion, Pharmaceutical Diagnostics, the Flyrcado product and the SOFIE acquisition as potential drivers of future revenue and radiopharmaceutical growth. GE HealthCare Q3 broad-based growth makes the bull case more compelling
• Positive Sentiment: Analyst targets moved higher: Mizuho raised its price target to $90 from $85, BNP Paribas increased its target to $100 from $96, and BTIG lifted its target to $83 from $75 while maintaining a buy rating. Mizuho Securities adjusts GE HealthCare price target
• Neutral Sentiment: A comparison with Haemonetics discusses GEHC’s relative value appeal among medical-products stocks, but does not introduce a material new company-specific catalyst. GEHC versus HAE value comparison
• Negative Sentiment: Jeannette Bankes, president and CEO of Patient Care Solutions, is leaving to become CEO of another company. The leadership transition is a modest uncertainty, although it was overshadowed by the earnings beat. GE HealthCare shares rise on higher results and outlook upgrade

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc is a global medical technology company that develops and provides products, services and digital solutions for healthcare providers. Its offerings are designed to support the diagnosis, treatment and monitoring of patients across hospitals, outpatient facilities, imaging centers and other care settings.

The company’s portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, molecular imaging, surgical imaging and X-ray equipment.